Click Here To Schedule A Consultation

Schedule a Consultation

  • Note: We do not offer virtual consultations
  • This field is for validation purposes and should be left unchanged.

Revance, New Frown Line Treatment – What is Revance?

When it comes to improving fine lines and wrinkles by using injectables most people have heard of Botox from a company called Allergan. A treatment that they may be less familiar with since it is brand new to the market (so new it is not out yet) is called Revance. This particular injectable is manufactured by the company Revance Therapeutics, Inc. and the treatment uses a substance called daxibotulinumtoxinA, or RT-002. Often the name daxibotulinumtoxinA is simply shortened to Daxi.

Both Botox and Revance are neuromodulator treatments. In simple terms, a neuromodulator treatment can take a few different forms (including injections such as delivered by Botox and Revance) with the goal to alter the behavior of nerve activity. In the case of Botox by blocking the signals sent to the nerves in the treatment area, allowing wrinkles and fine lines to relax, which in turn reduces their appearance. Another similarity that both products share, is that they are both classified as a neurotoxin.

Are Revance and Botox the Same? 

Revance and Botox share some similarities, but ultimately it should be noted that Revance is considered a completely new category of injectable product to treat glabellar lines / frown lines. For the consumer one of the most important differentiators is how long the treatment might potentially last between sessions. Clinical trials carried out on a group using Revance indicated that the injectable could last longer than six months between treatments. Longer term tests will indicate if all patient experiences are the same in this regard. Botox typically lasts for three to four months before you need to have another treatment to maintain your results.

Revance Release Date & Latest News

Ultimately, at the time of writing Revance has not been released to market yet but it is expected to arrive for consumers at some point in 2020. The treatment has been widely anticipated and this excitement has also shown in the stock prices for Revance Therapeutics, Inc. which has increased considerably in the last year.

In early February 2020, Revance filed a U.S. application for frown line treatment. When Revance does come to market (after FDA approval in the United States) then it is a product we’ll examine further to see if there will be a benefit for our own patients. Our blog will provide you with all the latest news that we have related to this product release. In the meantime, alternative and established dermatology treatments such as Botox and dermal fillers are still widely used and are available to treat frown lines and wrinkles.   You can learn more via its main website at

If you’re ready looking to reduce the appearance of fine lines, frown lines and wrinkles, there’s finally a solution that can help. Contact us online today or call our NYC based offices at 212-535-3088 to learn more about how Botox can potentially help you achieve the appearance you would like.

View other frown line treatment options such as Dysport

Related Topics

Call Us (212) 535-3088